Benefits of oral lubricants in dry mouth among old age home type II diabetic patients - A RCT

Effectiveness of oral moisturizers in Xerostomia among institutionalized Type II Diabetic patients - A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036995

Enrollment

Registered

2021-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K110- Atrophy of salivary gland

Interventions

Intervention1: Owet spray: The patient will be instructed to spray the oral mucosa and tongue using Owet mouth spray. Thrice daily for 30 days. Intervention2: Saleva mouth rinse: The patient will be i

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with mild, moderate, severe xerostomia will be eligible. 2. Patient diagnosed with Diabetic Mellitus with following Blood sugar levels are eligible Fasting blood sugar (FBS) levels over 126â??mg/dl. Random blood glucose levels over 200â??mg/dl. Two hours plasma glucose over 200 mg/dl or HbA1c level more than 6.5% 3. Patients who give the consent for participation in the study.

Exclusion criteria

Exclusion criteria: Patients having allergy to oral moisturizers. patients who had a salivary gland removal, and patients with Sjogrenâ??s syndrome. Patients who had received radiation therapy to the head and neck region.

Design outcomes

Primary

Measure	Time frame
XEROSTOMIATimepoint: I MONTH	—

Secondary

Measure	Time frame
ORAL HEALTH STATUSTimepoint: 1 MONTH	—

Countries

India

Contacts

Public ContactDr PRAVEEN JODALLI

YENEPOYA DENTAL COLLEGE

praveenjodalli@gmail.com9886244093

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026